Manager × security

McElhenny Sheffield Capital Management, LLC ABT holdings history

Who else holds this security? →

ABBOTT LABORATORIES · CUSIP 002824100 · CIK 1886813

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, McElhenny Sheffield Capital Management, LLC reported 13.01K ABT (shares), valued at $1.18M, or 0.29% of its reported non-derivative portfolio. Filed 2026-07-22.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.29%
Shares
13.01K
13,011
Reported value
$1.18M
USD

Shares increased 3.37%; reported value decreased 8.64%, and weight changed -0.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.29%13,011SEC filing ↗Filed Jul 22, 2026
Q1 20260.32%12,587SEC filing ↗Filed Apr 23, 2026
Q4 20250.39%12,657SEC filing ↗Filed Jan 21, 2026
Q3 20250.61%19,190SEC filing ↗Filed Oct 21, 2025
Q2 20250.68%18,871SEC filing ↗Filed Jul 24, 2025Amended
Q1 20250.94%18,871SEC filing ↗Filed Apr 16, 2025
Q4 20240.72%18,869SEC filing ↗Filed Jan 16, 2025
Q3 20240.71%18,855SEC filing ↗Filed Oct 21, 2024
Q2 20240.68%18,919SEC filing ↗Filed Jul 11, 2024
Q1 20240.77%18,919SEC filing ↗Filed Apr 17, 2024
Q4 20230.85%18,919SEC filing ↗Filed Jan 11, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20230.85%18,919$2.08MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Jan 11, 2024
Q1 20240.77%18,919$2.15MShares unchanged; reported value increased 3.26%, and weight changed -0.08 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 17, 2024
Q2 20240.68%18,919$1.97MShares unchanged; reported value decreased 8.58%, and weight changed -0.09 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 11, 2024
Q3 20240.71%18,855$2.15MShares decreased 0.34%; reported value increased 9.35%, and weight changed +0.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 21, 2024
Q4 20240.72%18,869$2.13MShares increased 0.07%; reported value decreased 0.72%, and weight changed +0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 16, 2025
Q1 20250.94%18,871$2.50MShares increased 0.01%; reported value increased 17.29%, and weight changed +0.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 16, 2025
Q2 20250.68%18,871$2.57MShares unchanged; reported value increased 2.53%, and weight changed -0.26 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 24, 2025
Q3 20250.61%19,190$2.57MShares increased 1.69%; reported value increased 0.14%, and weight changed -0.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 21, 2025
Q4 20250.39%12,657$1.59MShares decreased 34.04%; reported value decreased 38.30%, and weight changed -0.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 21, 2026
Q1 20260.32%12,587$1.29MShares decreased 0.55%; reported value decreased 18.51%, and weight changed -0.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 23, 2026
Q2 20260.29%13,011$1.18MShares increased 3.37%; reported value decreased 8.64%, and weight changed -0.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 22, 2026
McElhenny Sheffield Capital Management, LLC · ABBOTT LABORATORIES

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1886813","quarter":"2026Q2","cusip":"002824100"}

get_institutional_manager_history
{"cik":"1886813","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.